Literature DB >> 18363110

Caring for adult survivors of childhood cancer.

Daniel A Mulrooney1, Joseph P Neglia, Melissa M Hudson.   

Abstract

OPINION STATEMENT: Improved survival for pediatric oncology patients is a remarkable achievement of modern medicine. This success can be credited to the introduction of multimodality therapy and newer risk-based therapies developed and tested through national research protocols. With improved survival has come recognition of the many long-term effects of cancer and its treatment, such as vital organ dysfunction, subsequent malignancies, and psychosocial deficits. Childhood cancer survivors are vulnerable to adverse health outcomes which may not become apparent until years after therapy. These events may manifest well into adulthood when these individuals rarely return to their initial cancer center or seek preventive medical care. Risk-based follow-up can offer early detection and/or intervention and provides an opportunity to reduce cancer-related morbidity and mortality. An understanding of the late effects of cancer therapy is increasingly important for the medical community, both generalists and specialists-adult and pediatric, to better care for the growing population of adult survivors of childhood cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18363110     DOI: 10.1007/s11864-008-0054-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  69 in total

1.  Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands.

Authors:  N E Langeveld; M C Ubbink; B F Last; M A Grootenhuis; P A Voûte; R J De Haan
Journal:  Psychooncology       Date:  2003 Apr-May       Impact factor: 3.894

2.  Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.

Authors:  Steven E Lipshultz; Stuart R Lipsitz; Stephen E Sallan; Valeriano C Simbre; Seema L Shaikh; Suzanne M Mone; Richard D Gelber; Steven D Colan
Journal:  J Clin Oncol       Date:  2002-12-01       Impact factor: 44.544

3.  Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Authors:  Daniela Cardinale; Alessandro Colombo; Maria T Sandri; Giuseppina Lamantia; Nicola Colombo; Maurizio Civelli; Giovanni Martinelli; Fabrizio Veglia; Cesare Fiorentini; Carlo M Cipolla
Journal:  Circulation       Date:  2006-11-13       Impact factor: 29.690

Review 4.  The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures.

Authors:  Janine Nuver; Andries J Smit; Aleida Postma; Dirk Th Sleijfer; Jourik A Gietema
Journal:  Cancer Treat Rev       Date:  2002-08       Impact factor: 12.111

5.  Second neoplasms after treatment of childhood cancer in Slovenia.

Authors:  Janez Jazbec; Patricija Ećimović; Berta Jereb
Journal:  Pediatr Blood Cancer       Date:  2004-06       Impact factor: 3.167

Review 6.  Second cancers in survivors of childhood cancer.

Authors:  Smita Bhatia; Charles Sklar
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

7.  Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study.

Authors:  Joanna L Perkins; Yan Liu; Pauline A Mitby; Joseph P Neglia; Sue Hammond; Marilyn Stovall; Anna T Meadows; Ray Hutchinson; Zoann E Dreyer; Leslie L Robison; Ann C Mertens
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 50.717

8.  Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.

Authors:  Berrin Ergun-Longmire; Ann C Mertens; Pauline Mitby; Jing Qin; Glenn Heller; Weiji Shi; Yutaka Yasui; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 6.134

9.  Employment status among adult survivors in the Childhood Cancer Survivor Study.

Authors:  Jenny W Y Pang; Debra L Friedman; John A Whitton; Marilyn Stovall; Ann C Mertens; Leslie L Robison; Noel S Weiss
Journal:  Pediatr Blood Cancer       Date:  2008-01       Impact factor: 3.838

10.  Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Melissa M Hudson; Ann C Mertens; Yutaka Yasui; Wendy Hobbie; Hegang Chen; James G Gurney; Mark Yeazel; Christopher J Recklitis; Neyssa Marina; Leslie R Robison; Kevin C Oeffinger
Journal:  JAMA       Date:  2003-09-24       Impact factor: 157.335

View more
  5 in total

1.  Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.

Authors:  Andrew C Dietz; Shanthi Sivanandam; Suma Konety; Christopher L Kaufman; Ryan M Gage; Aaron S Kelly; Joseph P Neglia; Daniel A Mulrooney
Journal:  J Cancer Surviv       Date:  2013-12-07       Impact factor: 4.442

Review 2.  Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials.

Authors:  Lesley A Smith; Victoria R Cornelius; Christopher J Plummer; Gill Levitt; Mark Verrill; Peter Canney; Alison Jones
Journal:  BMC Cancer       Date:  2010-06-29       Impact factor: 4.430

3.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.

Authors:  Daniel A Mulrooney; Mark W Yeazel; Toana Kawashima; Ann C Mertens; Pauline Mitby; Marilyn Stovall; Sarah S Donaldson; Daniel M Green; Charles A Sklar; Leslie L Robison; Wendy M Leisenring
Journal:  BMJ       Date:  2009-12-08

4.  Threading the cloak: palliative care education for care providers of adolescents and young adults with cancer.

Authors:  Lori Wiener; Meaghann Shaw Weaver; Cynthia J Bell; Ursula M Sansom-Daly
Journal:  Clin Oncol Adolesc Young Adults       Date:  2015-01-09

5.  High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage.

Authors:  Elske Sieswerda; Anna Font-Gonzalez; Johannes B Reitsma; Marcel G W Dijkgraaf; Richard C Heinen; Monique W Jaspers; Helena J van der Pal; Flora E van Leeuwen; Huib N Caron; Ronald B Geskus; Leontien C Kremer
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.